Logo image of CAG.CA

COMPOSITE ALLIANCE GROUP INC (CAG.CA) Stock Fundamental Analysis

TSX-V:CAG - TSX Venture Exchange - CA20459W1032 - Common Stock - Currency: CAD

0.005  0 (-50%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CAG. CAG was compared to 82 industry peers in the Insurance industry. Both the profitability and financial health of CAG have multiple concerns. CAG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CAG has reported negative net income.
In the past year CAG had a positive cash flow from operations.
CAG had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CAG reported negative operating cash flow in multiple years.
CAG.CA Yearly Net Income VS EBIT VS OCF VS FCFCAG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M

1.2 Ratios

With a Return On Assets value of -21.59%, CAG is not doing good in the industry: 97.56% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -21.59%
ROE N/A
ROIC N/A
ROA(3y)-3.22%
ROA(5y)-12.79%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CAG.CA Yearly ROA, ROE, ROICCAG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2K -2K

1.3 Margins

The Gross Margin of CAG (66.05%) is better than 97.56% of its industry peers.
CAG's Gross Margin has declined in the last couple of years.
CAG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5YN/A
CAG.CA Yearly Profit, Operating, Gross MarginsCAG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

3

2. Health

2.1 Basic Checks

CAG does not have a ROIC to compare to the WACC, probably because it is not profitable.
CAG has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CAG has been increased compared to 5 years ago.
CAG has a better debt/assets ratio than last year.
CAG.CA Yearly Shares OutstandingCAG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CAG.CA Yearly Total Debt VS Total AssetsCAG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -1.50, we must say that CAG is in the distress zone and has some risk of bankruptcy.
CAG has a Altman-Z score of -1.50. This is amongst the best in the industry. CAG outperforms 93.90% of its industry peers.
CAG has a debt to FCF ratio of 56.33. This is a negative value and a sign of low solvency as CAG would need 56.33 years to pay back of all of its debts.
CAG has a Debt to FCF ratio of 56.33. This is amonst the worse of the industry: CAG underperforms 96.34% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 56.33
Altman-Z -1.5
ROIC/WACCN/A
WACC4.23%
CAG.CA Yearly LT Debt VS Equity VS FCFCAG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

2.3 Liquidity

CAG has a Current Ratio of 0.68. This is a bad value and indicates that CAG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CAG (0.68) is better than 89.02% of its industry peers.
A Quick Ratio of 0.68 indicates that CAG may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.68, CAG belongs to the top of the industry, outperforming 89.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68
CAG.CA Yearly Current Assets VS Current LiabilitesCAG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for CAG have decreased strongly by -403.61% in the last year.
CAG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.98%.
CAG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.41% yearly.
EPS 1Y (TTM)-403.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-150.88%
Revenue 1Y (TTM)-21.98%
Revenue growth 3Y28.41%
Revenue growth 5YN/A
Sales Q2Q%0.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CAG.CA Yearly Revenue VS EstimatesCAG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 5M 10M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CAG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CAG.CA Price Earnings VS Forward Price EarningsCAG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CAG.
Industry RankSector Rank
P/FCF 3.69
EV/EBITDA N/A
CAG.CA Per share dataCAG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CAG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMPOSITE ALLIANCE GROUP INC

TSX-V:CAG (5/9/2025, 7:00:00 PM)

0.005

0 (-50%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)04-30 2025-04-30
Earnings (Next)05-28 2025-05-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners37.17%
Ins Owner ChangeN/A
Market Cap551.15K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF 3.69
P/OCF 0.25
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY27.09%
OCF(TTM)0.02
OCFY394.21%
SpS0.1
BVpS-0.06
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.59%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.05%
FCFM 1.4%
ROA(3y)-3.22%
ROA(5y)-12.79%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5YN/A
F-Score4
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 56.33
Debt/EBITDA N/A
Cap/Depr 243.94%
Cap/Sales 18.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z -1.5
F-Score4
WACC4.23%
ROIC/WACCN/A
Cap/Depr(3y)141.37%
Cap/Depr(5y)100.22%
Cap/Sales(3y)11.04%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-403.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-150.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.98%
Revenue growth 3Y28.41%
Revenue growth 5YN/A
Sales Q2Q%0.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-557.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y108.03%
FCF growth 3Y40.24%
FCF growth 5YN/A
OCF growth 1Y530.07%
OCF growth 3Y67.5%
OCF growth 5YN/A